Gene · 2865
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Butyrate triggers neuronal signaling via release of colonic serotonin in a microfluidic model of gut-brain axis. | Am J Physiol Gastrointest Liver Physiol | 2026 | 42814738 | PubTator, text mining | PubMed |
| Short-Chain Fatty Acids in Sepsis: Mechanisms of Action and Therapeutic Advances. | Biomedicines | 2026 | 42792734 | PubTator, text mining | PubMed |
| Gut microbiota modulates nonalcoholic fatty liver disease (NAFLD) progression via regulation of gluconeogenesis: mechanisms and translational research. | Pharmacol Res | 2026 | 42749095 | PubTator, text mining | PubMed |
| Dietary plant polysaccharides as modulators of brain aging: mechanistic links to inflammaging, the gut brain axis and amyloid tau pathology. | Nutr Neurosci | 2026 | 42530981 | PubTator, text mining | PubMed |
| Gut-Brain Axis Mechanisms and Microbiome Abnormalities in Autism Spectrum Disorder and Therapeutic Implications. | Curr Neuropharmacol | 2026 | 42458949 | PubTator, text mining | PubMed |
| Microbiota-dependent biotransformation of apiin drives butyrate-associated protection against colitis. | NPJ Sci Food | 2026 | 42448689 | PubTator, text mining | PubMed |
| Interactions between nutrition, GLP-1 secretion, and composition of the gut microbiome. | Curr Opin Clin Nutr Metab Care | 2026 | 42165244 | PubTator, text mining | PubMed |
| Acidosis enables the NLRP3 inflammasome-inhibiting effects of β-hydroxybutyrate and short-chain carboxylic acids. | J Immunol | 2026 | 42153447 | PubTator, text mining | PubMed |
| The roles of free-fatty acid receptors in the pathophysiology of renal disorders. | J Pharmacol Exp Ther | 2026 | 42096898 | PubTator, text mining | PubMed |
| Gut microbiota-mediated metabolic dysregulation in type 2 diabetes and metabolic syndrome: emerging therapeutic targets beyond glycaemic control. | Diabetes Res Clin Pract | 2026 | 42086084 | PubTator, text mining | PubMed |
| Short-, medium-, versus long-chain fatty acids: mechanisms of immunomodulation and disease pathogenesis. | Cell Mol Immunol | 2026 | 42056219 | PubTator, text mining | PubMed |
| β-Hydroxybutyrate attenuates bronchial smooth muscle proinflammatory cytokine production and contraction. | Am J Physiol Cell Physiol | 2026 | 42021684 | PubTator, text mining | PubMed |
Effects of U62631.5 on short-chain fatty acid receptor 41(GPR41) and the related intestinal bacterium Butyricicoccus pullicaecorum after fecal bacterial transplantation in nonalcoholic fatty liver disease. | BMC Microbiol | 2026 | 41928077 | PubTator, text mining | PubMed |
| Small intestinal microbial fiber metabolism dysfunction in celiac disease. | Nat Commun | 2026 | 41917007 | PubTator, text mining | PubMed |
| Butyrate Silences MUC5AC in Airway Epithelial Cells Through Histone Deacetylation at Its Promoter Region. | Allergy Asthma Immunol Res | 2026 | 41914529 | PubTator, text mining | PubMed |
| The Role of Gut Microbiota in Postmenopausal Women: Implications for Lipid Metabolism and Targeted Nutritional Interventions. | Curr Nutr Rep | 2026 | 41903028 | PubTator, text mining | PubMed |
| The Polyphenol-Microbiota Axis: Molecular Mechanisms, Metabolic Pathways, and Therapeutic Perspectives in Human Health. | J Pers Med | 2026 | 41893010 | PubTator, text mining | PubMed |
| Decoding the HMO‒microbiome axis: bridging maternal milk to infant health outcomes. | Gut Microbes | 2026 | 41888026 | PubTator, text mining | PubMed |
| Fatty Acid-Sensing G Protein-Coupled Receptors in Skeletal Metabolism. | J Bone Metab | 2026 | 41850316 | PubTator, text mining | PubMed |
| Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies. | Ren Fail | 2026 | 41845903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2865/papers